Sepsis & infection

Bedside monitoring of the vascular response to norepinephrine in early septic shock: VNERi trajectories and comparison with dynamic clinical measures

J Clin Monit ComputPublished single-center prospective cohort

Authors' conclusion

Serial bedside VNERi monitoring is feasible and carries a partly independent signal that adds a small amount to dynamic clinical severity without outperforming it. These findings are hypothesis-generating and need validation in a hyporesponsive population.

Study context

Population
Adults with septic shock started on first-line norepinephrineadults with septic shock
Participants
94 adults
Exposure
VNERi course parameters (mean level, minimum, slope) vs ΔSOFA and lactate clearance for 28-day mortality
Outcome
28-day mortality
Follow-up
28 days

Main finding

As reported in the abstract

Mortality

32%

30/94

Observational data: associations, not effects.

Further findings

OutcomeHRP value
Higher VNERi(t) and survival (time-dependent Cox)Higher VNERi(t) · unadjusted0.48
Higher VNERi(t) and survival (time-dependent Cox)Higher VNERi(t) · after adjusting for SOFA(t); non-significant0.68P = 0.08

Baseline VNERi discrimination of 28-day mortality

AUC
0.59
Most had a preserved response

VNERi course parameters vs ΔSOFA discrimination of 28-day mortality · T0-T48

VNERi mean-level AUC
0.73
ΔSOFA AUC
0.84
Window-matched DeLong
P = 0.02
  • Did not outperform ΔSOFA

VNERi added to a dynamic clinical model

Integrated discrimination improvement
0.05-0.06
Likelihood-ratio
p ≈ 0.02
  • Small gain

Exploratory course phenotypes (latent class mixed model) and survival

Three exploratory course phenotypes separated survival
log-rank p = 0.002

Original publication

Bedside monitoring of the vascular response to norepinephrine in early septic shock: VNERi trajectories and comparison with dynamic clinical measures. J Clin Monit Comput. Published 9 October 2026. doi:10.1007/s10877-026-01516-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.